Related Experiment Video
Updated: Oct 12, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism
Chongge Pan1, Menghuan Li2, Jingzhou Wang1
1Department of Biochemistry and Molecular Biology, Shihezi University School of Medicine, Shihezi, China.
Aim/Introduction:
Obesity is considered an important risk factor for many metabolic disorders, especially type 2 diabetes mellitus, and microRNAs (miRNAs) play a vital role in the development of type 2 diabetes mellitus. Therefore, we conducted this study to investigate the role of miR-4431 in the obesity-associated pathobiology of type 2 diabetes mellitus.
Materials And Methods:
Subjects were divided into normal control (n = 36), obese (n = 36), and type 2 diabetes mellitus (n = 12) groups, and serum miR-4431 levels were analyzed. Adenovirus-vectored miR-4431 mimic or sponge was intraperitoneally injected into the normal diet group and the high-fat diet group (HFD) mice to investigate glucose tolerance, insulin sensitivity, and lipid levels. The downstream target genes of miR-4431 were predicted using bioinformatics, and they were verified in vitro.
Results:
Serum miR-4431 levels were significantly high in obese and type 2 diabetes mellitus individuals, and positively correlated with the body mass index and fasting plasma glucose levels. In HFD mice, miR-4431 levels in the serum, white adipose tissue, and liver were significantly increased. Moreover, miR-4431 impaired glucose tolerance, insulin sensitivity, and lipid metabolism in mice. Bioinformatic prediction suggested that TRIP10 and PRKD1 could be the downstream target genes of miR-4431. The HFD mice showed a remarkable reduction in the mRNA levels of TRIP10 and PRKD1 in the liver, which were countered by blocking miR-4431. In HepG2 and L02 cells, miR-4431 could downregulate TRIP10 and PRKD1 while blocking glucose uptake. The luciferase reporter assay showed that miR-4431 could bind TRIP10 and PRKD1 3'-UTR.
Conclusion:
miR-4431 targets TRIP10/PRKD1 and impairs glucose metabolism.
Insights
Obesity and type 2 diabetes are linked to elevated miR-4431 levels. This microRNA targets TRIP10/PRKD1, impairing glucose metabolism and insulin sensitivity in obesity.
Area of Science:
- Metabolic disease research
- Molecular biology
- Endocrinology
Background:
- Obesity is a major risk factor for metabolic disorders, particularly type 2 diabetes mellitus.
- MicroRNAs (miRNAs) are implicated in the pathogenesis of type 2 diabetes mellitus.
Purpose of the Study:
- To investigate the role of miR-4431 in obesity-associated type 2 diabetes mellitus.
- To explore the molecular mechanisms underlying miR-4431's function in metabolic regulation.
Main Methods:
- Serum miR-4431 levels were analyzed in normal, obese, and type 2 diabetes mellitus individuals.
- miR-4431 mimic or sponge was administered to high-fat diet (HFD) mice to assess glucose tolerance, insulin sensitivity, and lipid profiles.
- Bioinformatics and in vitro assays were used to identify and validate miR-4431's downstream targets.
Main Results:
- Serum miR-4431 levels were significantly elevated in obese and type 2 diabetes mellitus subjects, correlating with BMI and fasting glucose.
- HFD mice exhibited increased miR-4431 levels, leading to impaired glucose tolerance, insulin sensitivity, and dysregulated lipid metabolism.
- miR-4431 was found to downregulate TRIP10 and PRKD1 mRNA and protein levels, inhibiting glucose uptake in liver cells.
Conclusions:
- miR-4431 directly targets TRIP10 and PRKD1.
- miR-4431 plays a critical role in impairing glucose metabolism and exacerbating obesity-related type 2 diabetes mellitus.
- Targeting miR-4431 may offer a therapeutic strategy for metabolic disorders associated with obesity.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Cell Specific Gene Expression

